There are three types of lab testing methods/platforms available. They detect the virus or the patient’s response to the virus in different ways:
During the rise of viral RNA and viral antigen levels, a molecular (PCR or isothermal nucleic acid amplification based) or viral antigen test detects the presence of the virus. Often times, these molecular and viral antigen tests can be used as the primary basis for diagnosing your patient’s condition. Rather than going through the normal approval process, the U.S. Food and Drug Administration (FDA) is permitting all COVID-19 molecular and viral antigen tests to be cleared through its emergency use authorization (EUA) process during the pandemic. COVID-19 tests that go through the EUA process can request and secure a CLIA categorization.
Serology antibody tests detect the IgM and IgG antibodies that indicate your patient has developed an immune response to the virus but does not provide definitive evidence of a current infection. While experts say these tests will be important in the future, we have not seen widespread guidance on how these tests should be used. Serology antibody tests continue to be a focus in healthcare with the U.S. Food and Drug Administration (FDA) releasing very specific updates on these tests. The FDA has issued emergency use authorization (EUA) for some serology antibody tests. However, some serology antibody tests are being marketed without EUA. COVID-19 antibody serology tests without EUA currently default to a high complexity status. In addition, the accuracy and quality of those tests may vary greatly.
Co-Defend is now offering COVID-19 testing at your workplace. We have partnered with several CLIA certified labs across the United States to provide COVID-19 testing. Our healthcare providers will assist employers in coordinating the event, testing and reporting risk and help stop the spread of COVID-19.
Co-Defend also offers a saliva based Molecular Test that can be self-collected and shipped to our partner lab. Results of the test can confirm if the virus is detected in the saliva of an individual.
Our point-of-care testing platforms are small, lightweight, portable, and use RT-PCR technology, which is valued by clinicians and the scientific community for its high degree of accuracy.
All of our solutions are authorized by the FDA under Emergency Use Authorization (EUA). Contact us for additional information. We're ready to get your employees back to work and your students back to school!